EGFR and burning mouth syndrome: Approximately 25 to 40% of all non-small-cell lung cancer (NSCLC) patients will develop brain metastases (BMs) during their disease course, and the risk is even higher in patients with epidermal growth factor receptor (EGFR) mutation (1).